Published in Dig Dis Sci on July 15, 2010
Protein-protein interaction network of celiac disease. Gastroenterol Hepatol Bed Bench (2016) 0.82
Overexpression of Hsp70 confers cytoprotection during gliadin exposure in Caco-2 cells. Pediatr Res (2015) 0.75
Network biology: understanding the cell's functional organization. Nat Rev Genet (2004) 36.62
PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell (1999) 5.12
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity (2004) 4.36
A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity (2004) 3.76
Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med (1998) 3.13
Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat Med (1998) 2.90
Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol (2005) 2.49
Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A (2004) 2.33
Alterations in intestinal permeability. Gut (2006) 2.17
Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol (2002) 1.87
Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut (2007) 1.75
Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology (2007) 1.58
Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut (2006) 1.51
T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol (2001) 1.50
Genome-wide analysis of PPARalpha activation in murine small intestine. Physiol Genomics (2007) 1.45
Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum (1998) 1.39
Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol (2005) 1.33
The metabonomic signature of celiac disease. J Proteome Res (2009) 1.24
Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue. Gut (2008) 1.17
Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease. J Pediatr Gastroenterol Nutr (2007) 1.16
Heat shock proteins in immunity. Handb Exp Pharmacol (2006) 1.16
Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization. J Pharmacol Exp Ther (2004) 1.15
Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. Gut (2005) 1.11
Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease. Gastroenterology (1992) 1.10
Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease. Appl Environ Microbiol (2007) 1.04
Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice. Cell Death Differ (1997) 0.97
Jejunal mucosal immunoglobulins and complement in untreated coeliac disease. J Pathol (1977) 0.96
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line. Implications for celiac disease. J Biol Chem (2003) 0.94
PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94
Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits. BMC Immunol (2008) 0.91
Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity. Biochem J (2003) 0.90
Mass spectrometry analysis of gliadins in celiac disease. J Mass Spectrom (2007) 0.89
Associated autoantibodies in celiac disease. Autoimmun Rev (2007) 0.89
Identification of new celiac disease autoantigens using proteomic analysis. Proteomics (2003) 0.86
A functional candidate screen for coeliac disease genes. Eur J Hum Genet (2006) 0.83
Anti-actin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay. Clin Chem (2005) 0.82
Do gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with coeliac disease? Gut (2010) 0.82
Galectin-10, eosinophils, and celiac disease. Ann N Y Acad Sci (2009) 0.78
A new HLA-A*680106 allele identified in individuals with celiac disease from the Friuli area of northeast Italy. Tissue Antigens (2008) 0.76
Transglutaminase 2 in celiac disease: minireview article. Amino Acids (2004) 0.75
Protein expression profile of celiac disease patient with aberrant T cell by two-dimensional difference gel electrophoresis. Ann N Y Acad Sci (2007) 0.75
p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell (2005) 2.65
[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging (2006) 2.63
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum (2013) 2.52
Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc (2008) 1.69
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell (2008) 1.62
Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study. Onkologie (2009) 1.58
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A (2013) 1.44
The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition. Mol Cell Biol (2009) 1.43
Feasibility and diagnostic agreement in teledermatopathology using a virtual slide system. Hum Pathol (2007) 1.39
Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res (2008) 1.34
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood (2010) 1.27
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res (2009) 1.22
Food groups and risk of non-Hodgkin lymphoma: a multicenter, case-control study in Italy. Int J Cancer (2006) 1.21
p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. Mol Cancer Ther (2008) 1.16
Consensus guidelines on severe acute pancreatitis. Dig Liver Dis (2015) 1.12
Breast metastasis of primary colon cancer with micrometastasis in the axillary sentinel node: a metastasis that metastasized? Diagn Pathol (2011) 1.09
Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol (2011) 1.08
Clinical and dermoscopic features of porokeratosis of Mibelli. Arch Dermatol (2009) 1.08
Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo. Cell Cycle (2014) 1.07
Risk factors for ovarian cancer histotypes. Eur J Cancer (2007) 1.06
Identification of novel chimpanzee MHC class I and II alleles using an improved sequence-based typing strategy. Hum Immunol (2006) 1.04
Renal cell cancer and body size at different ages: an Italian multicenter case-control study. Am J Epidemiol (2007) 1.01
Reproductive, menstrual, and other hormone-related factors and risk of renal cell cancer. Int J Cancer (2008) 1.00
Interobserver agreement in describing video capsule endoscopy findings: a multicentre prospective study. Dig Liver Dis (2011) 0.99
Genome wide DNA-profiling of HIV-related B-cell lymphomas. Br J Haematol (2009) 0.97
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer. EMBO Mol Med (2013) 0.97
Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies. Leuk Lymphoma (2008) 0.95
PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94
Mammalian ATPsynthase monomer versus dimer profiled by blue native PAGE and activity stain. Electrophoresis (2007) 0.93
An effective multisource informed consent procedure for research and clinical practice: an observational study of patient understanding and awareness of their roles as research stakeholders in a cancer biobank. BMC Med Ethics (2013) 0.93
Differential proteomic analysis of hepatocellular carcinoma. Int J Oncol (2010) 0.92
Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature. Hum Pathol (2009) 0.91
Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol (2007) 0.91
Expression profiles in malignant fibrous histiocytomas: clues for differentiating 'spindle cell' and 'pleomorphic' subtypes. Eur J Cancer (2007) 0.91
Negative pigment network and shiny white streaks: a dermoscopic-pathological correlation study. Am J Dermatopathol (2014) 0.91
Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy. PLoS One (2011) 0.90
EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential. PLoS One (2012) 0.90
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. Neuroendocrinology (2008) 0.89
Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities. Clin Nucl Med (2012) 0.88
Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. J Am Acad Dermatol (2011) 0.88
Incidental Epstein-Barr virus associated atypical lymphoid proliferation arising in a left atrial myxoma: a case of long survival without any postsurgical treatment and review of the literature. Cardiovasc Pathol (2012) 0.85
Pitfalls in the dermoscopic diagnosis of amelanotic melanoma. J Am Acad Dermatol (2010) 0.85
Gastrointestinal stromal tumors: report of an audit and review of the literature. Eur J Cancer Prev (2009) 0.85
A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clin Exp Med (2012) 0.84
BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival. Head Neck (2010) 0.84
Stathmin is dispensable for tumor onset in mice. PLoS One (2012) 0.84
The versatile role of gliadin peptides in celiac disease. Clin Biochem (2012) 0.83
BRAF and KIT somatic mutations are present in amelanotic melanoma. Melanoma Res (2013) 0.83
KIR/HLA combination associated with the risk of complications in celiac disease. Int J Biol Markers (2011) 0.83
Diagnostic and therapeutic yield of single balloon enteroscopy in patients with suspected small-bowel disease: results of the Italian multicentre study. Dig Liver Dis (2012) 0.83
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease. Scand J Gastroenterol (2007) 0.83
Interferon-alpha for maintenance of follicular lymphoma. Cochrane Database Syst Rev (2010) 0.81
Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer (2010) 0.81
Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. PLoS One (2013) 0.81
Diet, obesity and breast cancer: an update. Front Biosci (Schol Ed) (2012) 0.80
HCV inhibits antigen processing and presentation and induces oxidative stress response in gastric mucosa. Proteomics Clin Appl (2008) 0.80
Pigmented mammary Paget's disease mimicking melanoma. Melanoma Res (2004) 0.80
Early gastric cancer: a single-institution experience on 60 cases. Suppl Tumori (2003) 0.80
Rhabdomyosarcoma of the skin resembling carcinosarcoma: report of a case and literature review. Am J Dermatopathol (2012) 0.80
Application of 2D-DIGE to formalin-fixed diseased tissue samples from hospital repositories: results from four case studies. Proteomics Clin Appl (2013) 0.80
Improving detection of celiac disease patients: a prospective study in iron-deficient blood donors without anemia in north Italy. Eur J Gastroenterol Hepatol (2014) 0.80
Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. Matrix Biol (2007) 0.79
Conservative treatment of microinvasive adenocarcinoma of uterine cervix: long-term follow-up. J Low Genit Tract Dis (2012) 0.79
Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations. Ann N Y Acad Sci (2009) 0.79
Role of the HLA class II: HCV-related disorders. Ann N Y Acad Sci (2007) 0.79
Comment re: Ran-GTP control of tumor cell mitosis. Cancer Res (2009) 0.79
Biomarkers in neuroendocrine tumors. Front Biosci (Schol Ed) (2010) 0.79
Galectin-10, eosinophils, and celiac disease. Ann N Y Acad Sci (2009) 0.78
In situ follicular lymphoma associated with nonlymphoid malignancies. Leuk Lymphoma (2011) 0.78
Biological and clinical markers in colorectal cancer: state of the art. Front Biosci (Schol Ed) (2010) 0.78
KRAS and BRAF mutational status in colon cancer from Albanian patients. Diagn Pathol (2014) 0.78
Exocrine and endocrine modulation in common gastric carcinoma. Am J Clin Pathol (2012) 0.78
Small bowel capsule endoscopy performance in octogenarians: a case-control study. J Gerontol A Biol Sci Med Sci (2010) 0.78
Skin lesions in melanoma and Kaposi's sarcoma. Case 2. Dermoscopic features of metastases from cutaneous melanoma mimicking benign nevi and primary melanoma. J Clin Oncol (2002) 0.78
Endoscopic placement of video capsule in a pediatric population. Gastrointest Endosc (2005) 0.78
Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment. Clin Colorectal Cancer (2012) 0.78
Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients. Anticancer Agents Med Chem (2013) 0.78
Huge renal cyst with parietal renal cell carcinoma, osseous metaplasia and a papillary adenoma: a case report with unique clinicopathological features and literature review. Virchows Arch (2008) 0.77
Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts. Future Med Chem (2014) 0.77
Genomic profiles of MALT lymphomas: variability across anatomical sites. Haematologica (2011) 0.77
Two-dimensional gel proteome reference map of human small intestine. Proteome Sci (2009) 0.76
Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC). Arch Gerontol Geriatr (2011) 0.76
Endomicroscopy and cancer: a new approach to the visualization of neoangiogenesis. Gastroenterol Res Pract (2012) 0.76
Absence of NOTCH1 gene mutations in MALT lymphomas. Br J Haematol (2011) 0.76
Amsterdam criteria II and endometrial cancer index cases for an accurate selection of HNPCC families. Tumori (2002) 0.76
Identification of proteins associated to multi-drug resistance in LoVo human colon cancer cells. Int J Oncol (2009) 0.76